FORMULATION AND EVALUATION OF COLON TARGETED DELAYED RELEASE MICROSPHERIC CAPSULES OF ALBENDAZOLE

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 4

Abstract

The aim of the present work was to prepare and evaluate the colon targeted delayed release microspheric capsules of albendazole. The preparation of albendazole microspheres by ionic gelation method avoids the usage of toxic organic solvents and considered to be relatively economical method. Calcium chloride was used as a counter ion and two polysaccharides namely sodium alginate and chitosan were used as a polymers that restrict the drug release in stomach and upper GIT and thus delayed the drug release. Different formulations were formulated by varying the polymers and counter ion concentration. These formulations were subjected to various evaluation parameters like percentage yield, particle size, surface morphology, drug entrapment efficiency, DSC study, flow property and in vitro drug release studies. The results of all parameters are tabulated and depicted graphically in the result and discussion section. The experimental results demonstrated that the prepared microspheres of albendazole for colon targeting may reduce the side effects of the drug caused by its absorption from the upper part of GIT when given in conventional dosage forms. Thus the albendazole microspheres have the potential to be used as a drug carrier for an effective colon targeted drug delivery system.

Authors and Affiliations

Dr. Asija Rajesh*| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-302020., Chaudhari Bharat| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-302020., Asija Sangeeta| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-302020., Patel Chirag J| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-302020., Patel Jaimin| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-302020., Patel Pinkesh| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-302020.

Keywords

Related Articles

ETHOSOMES: A NOVEL APPROACH IN TRANSDERMAL DELIVERY OF THE DRUGS

Skin acts as a major target as well as a principal barrier for topical/transdermal drug delivery. Despite the many advantages of this system, the major obstacle is the low diffusion rate of drugs across the stratum corne...

EXTRACTION AND ISOLATION OF α -AMYRIN ACETATE FROM THE FRUITS OF FICUS RACEMOSA

Ficus racemosa Linn belongs to the family Moraceae is popular in indigenous system of medicine like ayurveda, siddha, unani and homoeopathy. It has been known to posses diverse pharmacological activities. In the traditio...

INVESTIGATION OF IN VITRO ANTHELMINTIC ACTIVITY OF FICUS ELASTICA LEAVES

The World Health Organization estimates that a staggering two billion people harbor parasitic worm infections. The increasing of anthelmintic drug resistance and the high cost of anthelmintic drugs led to the development...

Formulation and evaluation of clozapine solidlipidnanoparticles with natural lipid

Solid lipid nanoparticles of poorly soluble drug (Clozapine) were prepared by using different lipids (Ghee, BBS-C, Dynasan118) with different surfactants (Acconon MC8 EP/NF, Gelucire 44/14, Labrasol, Tween 80, Capmul MC...

“QUALITY SYSTEM” TO HANDLE COMPLAINT AND RECALL IN PHARMACEUTICALS: A REVIEW

‘Quality' means compliance with statutory or agreed standards rather than grade of materials and workmanship. Manufacturers use many controls to make sure that the products they produce are safe. Sometimes, for many diff...

Download PDF file
  • EP ID EP1368
  • DOI -
  • Views 542
  • Downloads 37

How To Cite

Dr. Asija Rajesh*, Chaudhari Bharat, Asija Sangeeta, Patel Chirag J, Patel Jaimin, Patel Pinkesh (2013). FORMULATION AND EVALUATION OF COLON TARGETED DELAYED RELEASE MICROSPHERIC CAPSULES OF ALBENDAZOLE. Journal of Drug Discovery and Therapeutics, 1(4), 3-11. https://europub.co.uk./articles/-A-1368